Europe Glucose Monitoring Devices Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)


No. of Pages: 112    |    Report Code: BMIRE00029115    |    Category: Life Sciences

Europe Glucose Monitoring Devices Market
Buy Now

The Europe glucose monitoring devices market is expected to grow from US$ 5,248.87 million in 2022 to US$ 12,118.27 million by 2030. It is estimated to grow at a CAGR of 11.0% from 2022 to 2030.

Growing Medical Tourism in Developing Countries Fuel Europe Glucose Monitoring Devices Market

The emerging markets in developing countries are the major factor that gives the major players a better opportunity to expand their business. These are a major reason for the market growth during the forecast period. Most market players focus on emerging markets due to the prevalence of diabetes and the increasing popularity of glucose monitoring devices in the region. In India, medical science has progressed rapidly over the past few decades. Several international patients visit India in the pursuit of incredibly affordable medical care. Moreover, Poland has slowly become a favourite medical tourism destination in Europe. For instance, in Poland, medical treatment costs are often lower by 60–80% compared to the same benefits in the rest of the EU countries. The major reason for the growth of tourism is Poland's recognition and acceptance of the European Union. The rising medical tourism in emerging nations such as Poland is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

Europe Glucose Monitoring Devices Market Overview

The Europe glucose monitoring devices market has been segmented into the Germany, France, UK, Italy, Spain, Rest of Europe. The market growth in this region is attributed to the rising awareness of the diabetes diagnosis, increasing ageing population, and technological advancements in glucose monitoring thereby dominating the overall market growth.

Europe Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Glucose Monitoring Devices Market Segmentation

The Europe glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the Europe glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on application, the Europe glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on testing site, the Europe glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on end user, the Europe glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on country, the Europe glucose monitoring devices market is segmented into the Germany, UK, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe glucose monitoring devices market in 2022.   

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Europe glucose monitoring devices market.    


Europe Glucose Monitoring Devices Strategic Insights

Strategic insights for the Europe Glucose Monitoring Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-glucose-monitoring-devices-market-strategic-framework.webp
Get more information on this report

Europe Glucose Monitoring Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 5,248.87 Million
Market Size by 2030 US$ 12,118.27 Million
Global CAGR (2022 - 2030) 11.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Type
  • Continuous Glucose Monitoring Devices
  • Self-Glucose Monitoring Devices
By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
By Testing Type
  • Fingertip Testing
  • Alternate Site Testing
By End User
  • Healthcare Settings
  • Self/Homecare
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Senseonics Holdings Inc
  • Nipro Corp
  • GE HealthCare Technologies Inc
  • Terumo Corp
  • Get more information on this report

    Europe Glucose Monitoring Devices Regional Insights

    The geographic scope of the Europe Glucose Monitoring Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-glucose-monitoring-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Glucose Monitoring Devices Market

    • B. Braun SE
    • F. Hoffmann-La Roche Ltd
    • Medtronic Plc
    • Abbott Laboratories
    • Ypsomed Holding AG
    • Senseonics Holdings Inc
    • Nipro Corp
    • GE HealthCare Technologies Inc
    • Terumo Corp
    Frequently Asked Questions
    How big is the Europe Glucose Monitoring Devices Market?

    The Europe Glucose Monitoring Devices Market is valued at US$ 5,248.87 Million in 2022, it is projected to reach US$ 12,118.27 Million by 2030.

    What is the CAGR for Europe Glucose Monitoring Devices Market by (2022 - 2030)?

    As per our report Europe Glucose Monitoring Devices Market, the market size is valued at US$ 5,248.87 Million in 2022, projecting it to reach US$ 12,118.27 Million by 2030. This translates to a CAGR of approximately 11.0% during the forecast period.

    What segments are covered in this report?

    The Europe Glucose Monitoring Devices Market report typically cover these key segments-

    • Type (Continuous Glucose Monitoring Devices, Self-Glucose Monitoring Devices)
    • Application (Type 1 Diabetes, Type 2 Diabetes)
    • Testing Type (Fingertip Testing, Alternate Site Testing)
    • End User (Healthcare Settings, Self/Homecare)

    What is the historic period, base year, and forecast period taken for Europe Glucose Monitoring Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Glucose Monitoring Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Glucose Monitoring Devices Market?

    The Europe Glucose Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Senseonics Holdings Inc
  • Nipro Corp
  • GE HealthCare Technologies Inc
  • Terumo Corp
  • Who should buy this report?

    The Europe Glucose Monitoring Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Glucose Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now